- Home
- Articles
-
10.5606/tgkdc.dergisi.2012.172
Graft versus host disease after coronary bypass surgery
Yavuz Furuncuoğlu1, Cihan Şengül2, Emre Özker3
1Göztepe Medical Park Hastanesi, İç Hastalıkları Kliniği, İstanbul, Türkiye
2Göztepe Medical Park Hastanesi, Kardiyoloji Kliniği, İstanbul, Türkiye
3Göztepe Medical Park Hastanesi, Kalp ve Damar Cerrahisi Kliniği, İstanbul, Türkiye
DOI : 10.5606/tgkdc.dergisi.2012.172
Transfusion associated graft versus host disease (TA-GVHD)
is a rare disease with a high mortality rates. Due to low
potential to complete recovery with the treatment, supportive
care is usually administered. Late diagnosis is common
due to nonspecific signs and symptoms in routine clinical
practice. History of blood product transfusion is a critical
clue indicating this disease. In this article, we present a
74-year-old female case who was hospitalized in the intensive
care unit (ICU) due to fever, rash, elevated liver enzymes,
uremia, pancytopenia, jaundice, respiratory deficiency and
gastrointestinal bleeding at two weeks following coronary
artery bypass graft (CABG) surgery. She had received blood
from relative donors two weeks ago before CABG surgery.
The patient was diagnosed with graft versus host disease
through biopsy samples taken from skin rash. On day 4, the
patient died due to sepsis and disseminated intravascular
coagulation in the ICU.
Keywords : Blood transfusion; coronary artery bypass graft surgery; graft versus host disease
Viewed : 12213
Downloaded : 2764